…Braun Calcium salt for intravenous membrane stabilisation and calcium supplementation First-line intervention in hyperkalaemia with ECG changes: calcium restores the margin between resting membrane…

…good effect in musculoskeletal and postoperative pain, but with the most unfavourable cardiovascular profile in the class — the increase in risk for myocardial infarction, stroke…

…COX inhibitor, propionic acid derivative The first-line NSAID in Sweden and the one with the least cardiovascular risk at a low dose. A short…

…Braun Kaleorid Electrolyte concentrate for potassium replacement Potassium deficiency is corrected slowly because extracellular potassium is only two per cent of the body's total…

…curve for blood pressure flattens already at 2,5 mg, while the adverse effect curves for potassium, sodium, urate, and glucose continue to rise — higher…

…the active metabolite desmethyldiazepam up to four, so the concentration continues to rise for a week after initiation. That long tail is simultaneously the point…

…dosing and no routine monitoring. Lower risk of intracranial haemorrhage than warfarin — but the short half-life means a missed dose has consequences within hours.

…meals and overnight, with a largely flat profile over 24 hours and therefore a lower risk of nocturnal hypoglycaemia than NPH insulin. It is titrated…

…short notice. The disadvantages are continuous infusion, an unpredictable dose–response relationship due to binding to plasma proteins, and the risk of heparin-induced thrombocytopenia.

…symptomatic patient with HFrEF who remains above 70 beats per minute despite maximally tolerated beta-blockade, where SHIFT demonstrated reduced risk of heart failure hospitalisation.

…20–30 minutes after the infusion ends, it is useful in patients where beta-blockade is desirable but risky — impending heart failure, obstructive lung disease…